Cholesterol and recurrent events: A secondary prevention trial for normolipidemic patients

This publication has 15 references indexed in Scilit:

• Cholesterol reduction and its impact on coronary artery disease and total mortality
  The American Journal of Cardiology, 1995
• Range of serum cholesterol values in the population developing coronary artery disease
  The American Journal of Cardiology, 1995
• Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels
  The American Journal of Cardiology, 1995
• Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
  Journal of the American College of Cardiology, 1992
• Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
  The American Journal of Cardiology, 1991
• Published by Massachusetts Medical Society ,1990
• Background of the prevention of cardiovascular disease. II. Arteriosclerosis, hypertension, and selected risk factors.
  Circulation, 1989
• Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid
  Acta Medica Scandinavica, 1988
• Ischaemic Heart Disease: A Secondary Prevention Trial Using Clofibrate
  BMJ, 1971
• Trial of Clofibrate in the Treatment of Ischaemic Heart Disease: FIVE-YEAR STUDY BY A GROUP OF PHYSICIANS OF THE NEWCASTLE UPON TYNE REGION
  BMJ, 1971